Shannon Sullivan
Family · Reading, PANPI 1811755044
Payments from drug & device makers
Across 175 payments — averaging $18.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$605
- Pfizer$446
- Novo Nordisk$374
- Lilly USA, LLC$343
- AstraZeneca$225
- Novartis$177
- plus $1K from 18 others
What the payments were for
- Food & beverage$3,170100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 37 | $605 |
| Pfizer | 28 | $446 |
| Novo Nordisk | 18 | $374 |
| Lilly USA, LLC | 24 | $343 |
| AstraZeneca | 12 | $225 |
| Novartis | 8 | $177 |
| Boehringer Ingelheim | 7 | $171 |
| Amgen | 6 | $118 |
| Bayer | 5 | $99 |
| Phathom Pharmaceuticals, Inc. | 5 | $85 |
| Mannkind Corporation | 3 | $72 |
| Abbott | 3 | $63 |
| Lundbeck LLC | 2 | $55 |
| Sumitomo Pharma America, Inc. | 2 | $52 |
| Astellas Pharma US Inc | 2 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Viatris Specialty LLC | 2 | $36 |
| GSK | 2 | $31 |
| Exact Sciences | 2 | $29 |
| Ardelyx, Inc. | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Johnson & Johnson | 1 | $20 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| Ironwood Pharmaceuticals, Inc | 1 | $16 |
How this compares
$3,170 in reported general payments places this provider in the 90th percentile of 4,717 family providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 35 | $41,357 |
| JardianceEmpagliflozin | 22 | $20,419 |
| FarxigaDapagliflozin Propanediol | 25 | $17,293 |
| EliquisApixaban | 14 | $14,771 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 55 | $1,152 |
| Omeprazole | 39 | $581 |
| Sumatriptan Succinate | 24 | $457 |
| Atorvastatin Calcium | 69 | $401 |
| Lisinopril | 67 | $339 |
| Levothyroxine Sodium | 33 | $339 |
| Metoprolol Succinate | 32 | $267 |
| Rosuvastatin Calcium | 30 | $260 |
| Gabapentin | 30 | $250 |
| Amlodipine Besylate | 52 | $206 |
| Sertraline Hcl | 15 | $200 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $374 | $41,35735 claims |
| Boehringer IngelheimJardiance | $171 | $20,41922 claims |
| AstraZenecaFarxiga | $225 | $17,29325 claims |
| PfizerEliquis | $446 | $14,77114 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,717 family providers in Pennsylvania.
Other family in Reading
- Waylon SteeleReading$15K
- Kathleen ScholzPittsburgh$397K
- Shannon FitzgeraldAllison Park$370K
- Stephanie HarshbargerCamp Hill$317K
- Whitney BowlesFort Washington$253K
- Kweilynn GreenePittsburgh$139K
- Jessica LindenbergerPittsburgh$131K
- Kami NestlerWilkes Barre$129K
- Bethany ThomasPhiladelphia$126K
- Margaret RosenzweigPittsburgh$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.